Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neoforma.com Salvages Novation Deal, Scraps Eclipsys/HealthVision Merger

This article was originally published in The Gray Sheet

Executive Summary

Online medical equipment exchange Neoforma.com is handing over a hefty 45% of its equity to national health care alliances VHA, Inc. and University HealthSystems Consortium, part of the Novation group purchasing organization, under a revised agreement announced May 25.

You may also be interested in...



Neoforma Eliminating Transaction Fees For Device E-Procurement

Neoforma.com's adoption of a "value sharing" business model in lieu of a transaction fee-based model could pave the way for greater participation by major device manufacturers on the e-commerce exchange.

Neoforma Eliminating Transaction Fees For Device E-Procurement

Neoforma.com's adoption of a "value sharing" business model in lieu of a transaction fee-based model could pave the way for greater participation by major device manufacturers on the e-commerce exchange.

Neoforma.com Divests Units, Cedes Equity For $31 Mil. Cash Infusion

Neoforma.com is relinquishing more equity to strategic partners VHA Inc. and University HealthSystem Consortium, as well as an additional equity position to newly announced partner i2 Technologies, as part of an effort to raise about $30.5 mil. The financing was announced Jan. 25.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel